Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Share-based Compensation (2017 - 2025)

Historic Share-based Compensation for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to $70000.0.

  • Catheter Precision's Share-based Compensation rose 31176.47% to $70000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $277000.0, marking a year-over-year increase of 79354.84%. This contributed to the annual value of $54000.0 for FY2024, which is 9556.29% down from last year.
  • Catheter Precision's Share-based Compensation amounted to $70000.0 in Q3 2025, which was up 31176.47% from $98000.0 recorded in Q2 2025.
  • Catheter Precision's Share-based Compensation's 5-year high stood at $1.4 million during Q1 2023, with a 5-year trough of -$5000.0 in Q4 2023.
  • Over the past 5 years, Catheter Precision's median Share-based Compensation value was $91000.0 (recorded in 2025), while the average stood at $236947.4.
  • In the last 5 years, Catheter Precision's Share-based Compensation crashed by 10609.76% in 2023 and then surged by 141666.67% in 2025.
  • Quarter analysis of 5 years shows Catheter Precision's Share-based Compensation stood at $270000.0 in 2021, then tumbled by 69.63% to $82000.0 in 2022, then crashed by 106.1% to -$5000.0 in 2023, then surged by 460.0% to $18000.0 in 2024, then skyrocketed by 288.89% to $70000.0 in 2025.
  • Its last three reported values are $70000.0 in Q3 2025, $98000.0 for Q2 2025, and $91000.0 during Q1 2025.